Receive the latest updates from Matrix Medical in real time to understand product information.

In order to gain a deeper understanding of international market demand and strengthen clinical exchanges with overseas doctors. Recently, a delegation led by General Manager Ji Peihong from Hangzhou Matrix Medical Co., Ltd. conducted a multi day research trip to Russia and Singapore. Russia and Singapore, as two distinct healthcare markets, represent diversity and challenges. Through this survey, the company aims to conduct in-depth research on the unique needs and trends of these markets, in order to better position itself, ensure that products and services can meet the needs of the international market, and enhance the company's competitiveness.

Visit multiple overseas hospital research centers and have in-depth exchanges with KOLs

In order to further understand the current situation and trends of the local medical market, the Matrix Medical team visited several well-known local medical institutions and had academic exchanges and product discussions with doctors.

During the visit to medical institutions in Moscow, we had in-depth discussions with doctors about the clinical advantages and future development prospects of the key research and development product of Matrix, Collseal TM, in different application scenarios. The unique materials and technologies used in the product were introduced, and the excellent performance of the sealing component in liquid absorption, mechanical properties, and radial expansion size was demonstrated through on-site demonstrations. The product effectively improves the controllability and effectiveness of occlusion and hemostasis, and has the characteristics of speed, effectiveness, and safety. In addition, both teams shared the experience of doctors from different countries in using hemostatic devices during surgery, as well as how to choose the appropriate model and size of hemostatic devices based on patient conditions and surgical needs. During the communication, the doctors simulated the operation of the hemostatic device and provided valuable suggestions on how to improve its effectiveness and future market promotion, hoping to promote the application and popularization of the product in Russia.

S. S. YUDIN National Municipal Clinical Hospital Cardiovascular Expert Physician

Dr. Grigoryan Ashot Mikhailovich from the Russian "Mother and Baby" Group - Lapino Clinical Hospital

(Doctor of Medicine, Member of the Russian Society of Experts in Intravascular Diagnosis and Treatment, Director of the Radiology Intervention Department)

I. Dr. Dmitry Vladimirovich Skripnik from V. Davydovsky State Municipal Clinical Hospital

(Doctor of Medicine, Director of the Radiology Intervention Department and Cardiology Department at Moscow State A.I. Evdokimov Medical University)

At the National Heart Centre (NHCS) in Singapore, Mr. Ji Peihong, the General Manager, introduced the company's core product - Coronary Remodeling Catheters - to Professor Lin, the Director of the Catheterization Laboratory and Senior Consultant in the Department of Cardiology. He also shared the technological innovations and experimental data of the product. Professor Lin shared his clinical experience in related products and is also willing to contribute to the clinical trials of this project. He hopes to work together with medical professionals to provide a new treatment option for patients with coronary artery stenosis that is free of foreign body residue.

The National Heart Centre of Singapore (NHCS)

Professor Lin, Director of the Catheterization Laboratory and Senior Consultant of the Department of Cardiology

Participate in the Moscow Medical and Rehabilitation Exhibition in Russia

Visit medical agents and CRO service providers

During their stay in Russia, the company participated in the Moscow Medical and Rehabilitation Exhibition, which is the largest and most influential professional medical exhibition in Russia, gathering medical equipment manufacturers and medical service institutions from all over the world. Through in-depth communication with exhibitors and visitors, the Matrix team further understood the needs and trends of the Russian medical market and actively learned from the advanced experience of international peers.

At the same time, the Matrix Medical team visited well-known local medical agents in the field of vascular intervention in both countries, as well as the globally influential CRO pharmaceutical company - Tigermed Pte. Ltd. in Singapore. They had detailed discussions with each team on Juzheng's plans for product registration, sales, and other aspects, and all parties deeply explored feasible cooperation plans for the future.

This overseas research not only deepened Juzheng Medical's understanding of the international market, but also provided more ideas for the company's product development and services. In the future development, the Matrix team will adhere to the values of "safety and effectiveness, customer first, and continuous innovation", providing high-quality and efficient medical products and services for patients worldwide.